— Know what they know.
Not Investment Advice

SYUP OTC

Anbc, Inc.
1W: +0.0% 1M: +0.0% 3M: +50.0% YTD: +50.0% 1Y: +200.0% 3Y: -81.2% 5Y: -98.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 44 · $23881 mcap · 80M float · 0.067% daily turnover · Short 15% of daily vol

Income Trends

Revenue
$3M +10.0% ▲
Gross Profit
$2M +13.1% ▲
Operating Income
$1M +8.8% ▲
Net Income
$1M +7.2% ▲
EPS (Diluted)
$0.02 -70.9% ▼
EBITDA
$1M +6.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2007FY2016FY2017
Revenue$51K$3M$3M
YoY Growth+0.0%+0.0%+10.0%
Cost of Revenue$235K$1M$2M
Gross Profit-$184K$1M$2M
Gross Margin-361.1%47.8%49.1%
R&D Expenses$0$0$0
SG&A Expenses$18$128K$199K
Operating Expenses$18$128K$199K
Operating Income-$184K$1M$1M
Operating Margin-361.1%43.3%42.8%
Interest Expense$231K$290$83
Income Before Tax-$382K$1M$1M
Tax Expense-$7$31K$39K
Net Income-$382K$1M$1M
Net Margin-750.3%42.2%41.1%
EPS (Diluted)$-0.02$0.06$0.02
EBITDA-$26K$1M$1M
Shares Outstanding22M22M80M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms